Cytokines in Patients with Lung Cancer

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Scandinavian Journal of Immunology

• Publication date

  2003-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-3083.2003.01205.xPMID 12588664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bronchoalveolar lavage and the immunology of lung cancer

  2007cited by this paper
• Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer

  2002cited by this paper
• Lung cancer screening by low-dose spiral computed tomography.

  2001cited by this paper
• Novel nonantibiotic therapies for pneumonia: cytokines and host defense.

  2001cited by this paper
• Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer.

  2000cited by this paper
• Impact of Basic Research On Tomorrow's MedicineProinflammatory Cytokines

  2000cited by this paper
• Screening for lung cancer revisited and the role of sputum cytology and fluorescence bronchoscopy in a high-risk group.

  2000cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• Gene therapy of cancer.

  1998cited by this paper
• Clinical applications of TNF-alpha in cancer.

  1998cited by this paper
• Clinical applications of TNF-α in cancer

  1998cited by this paper
• Tumour immunology: false hopes--new horizons?

  1998cited by this paper
• Augmentation of naive, Th1 and Th2 effector CD4 Responses by IL‐6, IL‐1 and TNF

  1998cited by this paper
• Exogenous interleukin 2 regulates interleukin 6 and nitric oxide but not interferon gamma and tumor necrosis factor alpha production in bronchoalveolar leukocytes from patients with small cell lung cancer.

  1998cited by this paper
• Both TNF receptors are required for direct TNF‐mediated cytotoxicity in microvascular endothelial cells

  1998cited by this paper
• Bronchoalveolar lavage : A useful method for diagnosis of some pulmonary disorders

  1997cited by this paper
• The Th1/Th2 paradigm.

  1997cited by this paper
• IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB.

  1997cited by this paper
• The effect of NK cell activation by tumor cells on antigen-specific antibody responses.

  1997cited by this paper
• The host-tumor immune conflict: from immunosuppression to resistance and destruction.

  1997cited by this paper
• Cytokines, tumour-cell death and immunogenicity: a question of choice.

  1997cited by this paper
• CD4+ T-cell subsets and cytokines involved in peripheral tolerance.

  1997cited by this paper
• Lung cancer: A five-article symposium

  1997cited by this paper
• Human TH1 and TH2 Cells: Functional Properties, Regulation of Development and Role in Disease

  1996cited by this paper
• Functional diversity of helper T lymphocytes

  1996cited by this paper
• Cytostatic activity of alveolar macrophages from smokers and nonsmokers: role of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha.

  1994cited by this paper
• Nitrite/ nitrate and cytokine levels in bronchoalvelar lavage fluid of lung cancer patients

  1994cited by this paper
• Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing.

  1993cited by this paper
• Bronchogenic carcinoma: immunologic aspects.

  1993cited by this paper
• Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages.

  1993cited by this paper
• Role of Interleukin‐l in Infectious Diseases

  1992cited by this paper
• Cytokines of the lung.

  1992cited by this paper
• Role of interleukin-1 in infectious diseases.

  1992cited by this paper
• IL-10 inhibits cytokine production by activated macrophages.

  1991cited by this paper
• Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro.

  1991cited by this paper
• More insights into the complex physiology of TNF.

  1991cited by this paper
• Bronchoalveolar lavage in the diagnosis of cancer

  1990cited by this paper
• Cytotoxic mechanism of tumor necrosis factor‐α

  1990cited by this paper
• Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: A molecular mechanism regulating cellular proliferation that targets intracellular iron

  1990cited by this paper
• Lung cancer.

  1990cited by this paper
• Enhanced production of IL-6 in tumor-bearing mice and determination of cells responsible for its augmented production.

  1990cited by this paper
• Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.

  1988cited by this paper
• Structure and Function of Interleukin 4 and 5

  1988cited by this paper
• Expression and secretion of type beta transforming growth factor by activated human macrophages.

  1987cited by this paper
• Tumor killing by human alveolar macrophages and blood monocytes. Decreased cytotoxicity of human alveolar macrophages.

  1986cited by this paper

• Inflammation-Driven Genomic Instability: A Pathway to Cancer Development and Therapy Resistance

  2025cites this paper
• The role of bronchial washing of transforming growth factor β1 as a prognostic biomarker of advanced stages of non-small cell lung cancer

  2025cites this paper
• Interleukin-1β and cancer immune response.

  2025cites this paper
• Inflammatory cytokines and specific factors influencing lung cancer progression

  2025cites this paper
• Cytokine profiling identifies circulating IL-2, IL23 and sPD-L1 as prognostic biomarkers for treatment outcomes in non-small cell lung cancer patients undergoing anti-PD1 therapy

  2025cites this paper
• Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes

  2025cites this paper
• Unraveling the molecular-pathological characteristics and cellular complexity of the tumor immune microenvironment in metastatic non-small cell lung cancer

  2025cites this paper
• Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma

  2024cites this paper
• SPRi Biosensor for Simultaneous Determination of HIF-1α, Angiopoietin-2, and Interleukin-1β in Blood Plasma

  2024cites this paper
• Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity

  2023cites this paper
• Serum and Bronchoalveolar Lavage Fluid Levels of Cytokines in Patients with Lung Cancer and Chronic Lung Disease: A Prospective Comparative Study

  2023influential citation
• Characteristics of tumor microenvironment and novel immunotherapeutic strategies for non-small cell lung cancer

  2022cites this paper
• Impact of SARS-CoV-2 on lung cancer patient under immunotherapy

  2022cites this paper
• Interactions between COVID-19 and Lung Cancer: Lessons Learned during the Pandemic

  2022cites this paper
• Detection of IL1β Gene in Sudanese Patients with Gliomas Tumor in Khartoum state, Sudan

  2022cites this paper
• Oncogenic Mutation BRAF V600E Changes Phenotypic Behavior of THLE-2 Liver Cells through Alteration of Gene Expression

  2022cites this paper
• A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications

  2021influential citation
• Studies in lung cancer cytokine proteomics: a review

  2021cites this paper
• Evaluation of cytokines in the tumor microenvironment of lung cancer using bronchoalveolar lavage fluid analysis

  2021cites this paper
• Golden berry 4β-hydroxywithanolide E prevents tumor necrosis factor α-induced procoagulant activity with enhanced cytotoxicity against human lung cancer cells

  2021cites this paper
• Interleukin-1β weakens paclitaxel sensitivity through regulating autophagy in the non-small cell lung cancer cell line A549

  2021cites this paper
• Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk

  2020cites this paper
• Interleukin-1β and Cancer

  2020cites this paper
• Anti-inflammatory and anticancer activities of Naringenin-loaded liquid crystalline nanoparticles in vitro.

  2020cites this paper
• Iranian Version of Cancer-Related Fatigue Questionnaire: Construction and Validation

  2019cites this paper
• Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer

  2019cites this paper
• Evaluation of the antitumor activity of Solenostemma argel in the treatment of lung carcinoma induced in rats

  2018cites this paper
• Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma

  2018cites this paper
• Functional analysis of polymorphisms in the COX-2 gene and risk of lung cancer

  2017cites this paper
• High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer

  2017cites this paper
• Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLC

  2016cites this paper
• Relationship between fatigue, sleep quality and inflammatory cytokines during external beam radiation therapy for prostate cancer: A prospective study.

  2016cites this paper
• Differential expression of inflammasomes in lung cancer cell lines and tissues

  2015cites this paper
• Macrophage phenotype and function in primary lung cancer

  2015influential citation
• Systemic and alveolar inflammatory response in the dependent and nondependent lung in patients undergoing lung resection surgery: A prospective observational study

  2015cites this paper
• Genetic polymorphisms involved in the inflammatory response and lung cancer risk: a case-control study in Japan.

  2014cites this paper
• Bronchial cytokine level changes in lung cancer operations.

  2014cites this paper
• Lack of association between −174G>C and −634C>G polymorphisms in interleukin-6 promoter region and lung cancer risk: a meta-analysis

  2014cites this paper
• Association between TNF-α gene 308G>A polymorphism and lung cancer risk: a meta-analysis

  2014cites this paper
• Alveolar Macrophage Polarisation in Lung Cancer

  2014cites this paper
• Genetic susceptibility to lung cancer--light at the end of the tunnel?

  2013cites this paper
• Involvement of interleukin‐1β mediated nuclear factor κB signalling pathways to down‐regulate prostate‐specific antigen and cell proliferation in LNCaP prostate cancer cells

  2012cites this paper
• Reticular erythematous mucinosis – a review

  2012cites this paper
• Novel cytokines: IL-27, IL-29, IL-31 and IL-33. Can they be useful in clinical practice at the time diagnosis of lung cancer?

  2012cites this paper
• Elevated levels of anti inflammatory IL-10 and pro inflammatory IL-17 in malignant pleural effusions

  2012cites this paper
• [Comparison of local and systemic inflammatory markers in patients with community-acquired pneumonia and pneumonia coexisting with lung cancer].

  2011cites this paper
• Preparation and evaluation of PLGA microparticles as carrier for the pulmonary delivery of rhIL-2 : I. Effects of some formulation parameters on microparticle characteristics

  2011cites this paper
• Neutrophilic airways inflammation in lung cancer: the role of exhaled LTB-4 and IL-8

  2011cites this paper
• Osteopontin as a marker of weight loss in lung cancer

  2011cites this paper
• Asthma and risk of lung cancer

  2011cites this paper
• Comparison of selected markers of local and systemic inflammation in patients with community-acquired pneumonia and pneumonia co-existing with lung cancer

  2011cites this paper
• The role of inflammation and matrix proteins in airway remodelling

  2011cites this paper
• Polymorphisms in Inflammation-Related Genes and Risk of Smoking-associated Lung Cancer and Chronic Obstructive Pulmonary Disease

  2011cites this paper
• Asthma and risk of lung cancer

  2011cites this paper
• Cytokines in bronchoalveolar lavage fluid and serum of lung cancer patients during radiotherapy - Association of interleukin-8 and VEGF with survival.

  2010cites this paper
• Cytokines and Growth Factors Stimulate Hyaluronan Production: Role of Hyaluronan in Epithelial to Mesenchymal-Like Transition in Non-Small Cell Lung Cancer

  2010cites this paper
• Involvement of macrophage inflammatory protein 1alpha (MIP1alpha) in promotion of rat lung and mammary carcinogenic activity of nanoscale titanium dioxide particles administered by intra-pulmonary spraying.

  2010cites this paper
• Interaction of cyclooxygenase 2 genotype and smoking habit in Taiwanese lung cancer patients.

  2010cites this paper
• Antioxidants, Cytokines and Markers of Oxidative Stress in Lung Cancer

  2010cites this paper
• Prognostic significance of serum adipokine levels in colorectal cancer patients.

  2009cites this paper
• Serum Concentrations of Cytokines and Lung Cancer Survival in African Americans and Caucasians

  2009cites this paper
• Upregulation of interleukin‐1 by Epstein–Barr virus latent membrane protein 1 and its possible role in nasopharyngeal carcinoma cell growth

  2009cites this paper
• Cytokine and Cytokine Receptor Single-Nucleotide Polymorphisms Predict Risk for Non–Small Cell Lung Cancer among Women

  2009cites this paper
• Natriuretic peptide receptor a as a novel anticancer target.

  2008cites this paper
• TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer.

  2008cites this paper
• TNF-alpha/IL-1/NF-kappaB transduction pathway in human cancer prostate.

  2008cites this paper
• Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.

  2008cites this paper
• TNF-a/IL-1/NF-KB transduction pathway in human cancer prostate

  2008cites this paper
• Review TNF-α/IL-1/NF-κB transduction pathway in human cancer prostate

  2008cites this paper
• Defective antitumor responses in CX3CR1‐deficient mice

  2007cites this paper
• Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation.

  2007cites this paper
• Association of common polymorphisms in inflammatory genes with risk of developing cancers of the upper aerodigestive tract

  2007cites this paper
• Review. TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: an early target in anticancer therapeutic strategy.

  2007cites this paper
• Diagnostic Accuracy of Cytokine Levels (TNF-α, IL-2 and IFN-γ) in Bronchoalveolar Lavage Fluid of Smear-Negative Pulmonary Tuberculosis Patients

  2007cites this paper
• Alveolar macrophage function is altered in patients with lung cancer

  2006cites this paper
• Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer.

  2006cites this paper
• Joint effect of asthma/atopy and an IL-6 gene polymorphism on lung cancer risk among lifetime non-smoking Chinese women.

  2006cites this paper
• A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population.

  2005cites this paper
• TRANSPORT TRANSENDOTHÉLIAL DE GÈNES : ÉTUDES DYNAMIQUES DU PASSAGE SÉLECTIF DE POLYPLEXES AU TRAVERS DE L'ENDOTHÉLIUM VASCULAIRE PULMONAIRE.

  2005cites this paper
• Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer

  2005cites this paper
• Reticular erythematous mucinosis (REM) with telangiectasias associated with essential thrombocytosis and lung carcinoma.

  2005cites this paper
• Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis.

  2005cites this paper
• Interleukin‐1 (IL‐1α and IL‐1β) and its receptors (IL‐1RI, IL‐1RII, and IL‐1Ra) in prostate carcinoma

  2004cites this paper
• Evidence for immune defects in breast and lung cancer patients

  2004cites this paper
• Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma.

  2004cites this paper
• Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.

  2004cites this paper
• Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer.

  2003cites this paper